title: Successful protocol of anaesthesia for measuring transepithelial nasal potential difference in spontaneously breathing mice.
abstract: Numerous difficulties arise during in vivo measurements of transepithelial nasal potential difference (PD) in mice, such as inadequate duration and depth of anaesthesia, bronchoaspiration of solutions perfused in the nose, and respiratory and/or cardiovascular depression. Anaesthesia was induced in adult C57 mice with intraperitoneal injection of a combination of fentanyl, droperidol and medetomidine, each of these at either a small dose (0.20, 10 and 0.33 mg/kg, respectively) or at a large dose (0.40, 20 and 0.40 mg/kg, respectively), combined with a fixed dose of 0.375 microg clonidine. In order to establish a pharmacokinetic-pharmacodynamic relationship, blood concentrations of the first three drugs were measured in 24 animals by liquid-chromatography tandem mass spectrometry. At the end of the experiment, naloxone, a competitive morphinic antagonist, and atipamezole, an alpha-2 adrenergic antagonist, were administered. Bronchoaspiration was prevented by tilting the animal head downwards and by absorbing the excess fluid from the opposite nostril and from the oral cavity. Optimal assessment of anaesthesia associated with regular respiration, loss of blink, pupillary and pedal withdrawal reflexes was obtained with doses of fentanyl, droperidol and medetomidine corresponding to 0.20, 20 and 0.40 mg/kg, respectively. Blood concentrations of fentanyl around 17 ng/mL induced loss of respiratory efforts and were followed by death during the experiment. Integrity of ion transport was demonstrated under continuous perfusion by successive depolarization after amiloride and repolarization after chloride-free solution. The combination investigated in this study lead to adequate surgical anaesthesia (stage III, plane 2) for prolonged nasal PD measurements in spontaneously breathing mice.
authors.affiliation: Department of Clinical Chemistry, Université Catholique de Louvain, Brussels, Belgium. teresinha.leal@clin.ucl.ac.be
authors.forename: T
authors.initials: T
authors.lastname: Leal
authors.forename: J
authors.initials: J
authors.lastname: Lebacq
authors.forename: R
authors.initials: R
authors.lastname: Vanbinst
authors.forename: Ch
authors.initials: Ch
authors.lastname: Lederman
authors.forename: M
authors.initials: M
authors.lastname: De Kock
authors.forename: P
authors.initials: P
authors.lastname: Wallemacq
mesh_terms: D000758:Anesthesia / Q000662:veterinary*; D019162:Anesthetics, Combined / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D004305:Dose-Response Relationship, Drug; D004329:Droperidol / Q000008:administration & dosage / Q000493:pharmacokinetics; D004553:Electric Conductivity; D004847:Epithelial Cells / Q000502:physiology; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage / Q000493:pharmacokinetics; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D020926:Medetomidine / Q000008:administration & dosage / Q000493:pharmacokinetics; D008564:Membrane Potentials / Q000502:physiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D009297:Nasal Mucosa / Q000502:physiology*; D021241:Spectrometry, Mass, Electrospray Ionization
chemical_list: D019162:Anesthetics, Combined; D020926:Medetomidine; D004329:Droperidol; D005283:Fentanyl